Advertisement
Screener

Femasys Inc. (FEMY) Overview

Femasys Inc. (FEMY) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -1.33; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.00; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.10; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -3.18; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$1.98$3.20$5.17$8.36$13.51$21.842025-09-292026-09-29$1.98$4.81$11.70$28.46$69.24$168.422021-09-292026-09-29$1.98$5.21$13.75$36.25$95.58$252.002021-06-182026-09-29$1.98$5.21$13.75$36.25$95.58$252.002021-06-182026-09-29$1.98$5.21$13.75$36.25$95.58$252.002021-06-182026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$2.09
Previous close
$2.38
Change
-$0.29
Change (%)
-12.18%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

FEMY
-81.93%
S&P 500
(m)

1 year

FEMY
-70.43%
S&P 500
(m)

3 years

FEMY
-96.51%
S&P 500
(m)

5 years

FEMY
-98.55%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -1.33

-3.26-2.40-1.54-0.680.1831 Mar 2025: estimate (m); actual -0.2331 Mar 2025(m)30 Jun 2025: estimate (m); actual -3.1830 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.1030 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.0031 Mar 2026(m)30 Jun 2026: estimate (m); actual -1.3330 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-1.33(m)(m)
1 Jan 202631 Mar 2026(m)0.00(m)(m)
1 Jul 202530 Sept 2025(m)-0.10(m)(m)
1 Apr 202530 Jun 2025(m)-3.18(m)(m)
1 Jan 202531 Mar 2025(m)-0.23(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.47

-1.20-0.97-0.75-0.52-0.2931 Dec 2021: estimate (m); actual -1.1231 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.9631 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.9331 Dec 2023(m)31 Dec 2024: estimate (m); actual -0.8531 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.4731 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.47(m)(m)
1 Jan 202431 Dec 2024(m)-0.85(m)(m)
1 Jan 202331 Dec 2023(m)-0.93(m)(m)
1 Jan 202231 Dec 2022(m)-0.96(m)(m)
1 Jan 202131 Dec 2021(m)-1.12(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 0.33M ■ Earnings -4.47M — Profit margin -1346.81%

-5.11M-1347.8%-2.91M-831.8%-0.71M-315.8%1.48M200.1%30 Sept 2025: revenue 0.73M; earnings -4.19M; profit margin -575.11%30 Sept 202531 Dec 2025: revenue 0.81M*; earnings -3.95M*; profit margin -485.66%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 0.42M; earnings 0.85M; profit margin 199.13%31 Mar 202630 Jun 2026: revenue 0.33M; earnings -4.47M; profit margin -1346.81%30 Jun 2026

31 Dec 2025 ■ Revenue 2.29M ■ Earnings -18.63M — Profit margin -812.27%

-21.35M-1330.1%-12.62M-1157.1%-3.90M-984.2%4.83M-811.3%31 Dec 2022: revenue 1.21M; earnings -11.39M; profit margin -944.62%31 Dec 202231 Dec 2023: revenue 1.07M; earnings -14.25M; profit margin -1329.06%31 Dec 202331 Dec 2024: revenue 1.63M; earnings -18.82M; profit margin -1155.03%31 Dec 202431 Dec 2025: revenue 2.29M; earnings -18.63M; profit margin -812.27%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$2.09(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$2.09High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning FEMY

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-11.77M
Profit margin
-511.77%
Return on assets · 12 month
-90.28%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
74.50K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-17.72%*
Total return · month
-33.91%*
Total return · quarter
-44.34%*
Total return · half year
-78.40%*
Total return · year to date
-81.93%*
Total return · 1 year
-70.43%*
Total return · 3 years
-96.51%*
Total return · 5 years
-98.55%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$2.30M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Femasys Inc. Overview

View more →

(m)

(m)

SEC CIK
1339005
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
3950 JOHNS CREEK COURT, SUITE 100, SUWANEE, Georgia, 30024, United States
Fiscal year end
1231
Phone
770-500-3910

Similar stocks

Stock NameCountryMarket CapPE Ratio
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
Modular Medical, Inc. (MODD)United States$0.018B-0.88
SeaStar Medical Holding Corp (ICU)United States$0.015B-1.14
CERENOME, INC. (CNSY)United States$0.014B
ACCURAY INC (ARAY)United States$0.027B-0.63
Glucotrack, Inc. (GCTK)United States$0.027B
Sintx Technologies, Inc. (SINT)United States$0.012B-1.10
NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)United States$0.012B
Picard Medical, Inc. (PMI)United States$0.011B-0.01